Skip to content

In the BioHarmony Drug Report Database

Dalfopristin

Synercid (dalfopristin) is a small molecule pharmaceutical. Dalfopristin was first approved as Synercid on 1999-09-21. It is used to treat bacterial infections, staphylococcal skin infections, and streptococcal infections in the USA.
Trade Name Synercid
Common Name Dalfopristin
Indication bacterial infections, staphylococcal skin infections, streptococcal infections
Drug Class Antibacterials, pristinamycin derivatives
Dalfopristin
Get full access now